Basic Information
Basic information for MIR9-3HG-241-23aa-2
Peptide Name MIR9-3HG-241-23aa-2
Genome Position chr15:89398234-89398302[+]
Species Human
Peptide Sequence MRIAPRPAPVLPRGWPGVGLWEG
Peptide Length 23
Unique No (MIR9-3HG-201-23aa-2,MIR9-3HG-212-23aa-2,MIR9-3HG-213-23aa-2,MIR9-3HG-214-23aa-2,MIR9-3HG-218-23aa-2,MIR9-3HG-219-23aa-2,MIR9-3HG-220-23aa-2,MIR9-3HG-221-23aa-2,MIR9-3HG-222-23aa-2,MIR9-3HG-226-23aa-3,MIR9-3HG-227-23aa-2,MIR9-3HG-233-23aa-2,MIR9-3HG-246-23aa-3,MIR9-3HG-247-23aa-2,MIR9-3HG-251-23aa-2,MIR9-3HG-252-23aa-3,MIR9-3HG-253-23aa-2)
Grand Average of Hydropathicity -0.1043
Relative Molecular Mass 2909.3
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000666816;MIR9-3HG-241
Transcript Length 4053
Coding Ability 0.5181
DNA Sequence Corresponding to Peptide ATGAGGATTGCTCCGAGGCCTGCTCCAGTACTTCCCAGAGGCTGGCCTGGTGTGGGGCTCTGGGAAGGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :